Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Boileau

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2015
Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography studyShinichiro Nakajima, Fernando Caravaggio, Isabelle Boileau, et al.
Neuroimage. Reports|May 26, 2023
Fatty acid amide hydrolase levels in brain linked with threat-related amygdala activationDuncan Gj Green, Duncan J Westwood, Jinhee Kim, et al.
Neurobiology of Disease|April 8, 2014
Is brain gliosis a characteristic of chronic methamphetamine use in the human?Junchao Tong, Paul Fitzmaurice, Yoshiaki Furukawa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?Isabelle Boileau, Pablo Rusjan, Sylvain Houle, et al.
Human Psychopharmacology|April 26, 2021
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging studyStephen J Kish, Gerald O'Leary, Mortimer Mamelak, et al.
Human Brain Mapping|July 29, 2017
The relationship between subcortical brain volume and striatal dopamine D<sub>2/3</sub> receptor availability in healthy humans assessed with [<sup>11</sup> C]-raclopride and [<sup>11</sup> C]-(+)-PHNO PETFernando Caravaggio, Jun Ku Chung, Eric Plitman, et al.
Addiction (Abingdon, England)|November 22, 2012
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]racloprideIsabelle Boileau, Doris Payer, Bindiya Chugani, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2021
Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [<sup>11</sup>C]-(+)-PHNO studyChidera C Chukwueke, Christina N Nona, Matthew D McPhee, et al.
Frontiers in Psychiatry|January 27, 2023
Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker studySarah E Watling, Samantha Jagasar, Tina McCluskey, et al.
Brain Communications|July 17, 2025
[<sup>18</sup>F]SynVest-1 PET imaging in people with Parkinson's diseaseSarah L Martin, Carme Uribe, Kimberly L Desmond, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 11, 2015
Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography studyShinichiro Nakajima, Fernando Caravaggio, Isabelle Boileau, et al.
Neuroimage. Reports|May 26, 2023
Fatty acid amide hydrolase levels in brain linked with threat-related amygdala activationDuncan Gj Green, Duncan J Westwood, Jinhee Kim, et al.
Neurobiology of Disease|April 8, 2014
Is brain gliosis a characteristic of chronic methamphetamine use in the human?Junchao Tong, Paul Fitzmaurice, Yoshiaki Furukawa, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 26, 2008
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?Isabelle Boileau, Pablo Rusjan, Sylvain Houle, et al.
Human Psychopharmacology|April 26, 2021
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging studyStephen J Kish, Gerald O'Leary, Mortimer Mamelak, et al.
Human Brain Mapping|July 29, 2017
The relationship between subcortical brain volume and striatal dopamine D<sub>2/3</sub> receptor availability in healthy humans assessed with [<sup>11</sup> C]-raclopride and [<sup>11</sup> C]-(+)-PHNO PETFernando Caravaggio, Jun Ku Chung, Eric Plitman, et al.
Addiction (Abingdon, England)|November 22, 2012
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]racloprideIsabelle Boileau, Doris Payer, Bindiya Chugani, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 2021
Exploring regulation and function of dopamine D3 receptors in alcohol use disorder. A PET [<sup>11</sup>C]-(+)-PHNO studyChidera C Chukwueke, Christina N Nona, Matthew D McPhee, et al.
Frontiers in Psychiatry|January 27, 2023
Imaging oxidative stress in brains of chronic methamphetamine users: A combined 1H-magnetic resonance spectroscopy and peripheral blood biomarker studySarah E Watling, Samantha Jagasar, Tina McCluskey, et al.
Brain Communications|July 17, 2025
[<sup>18</sup>F]SynVest-1 PET imaging in people with Parkinson's diseaseSarah L Martin, Carme Uribe, Kimberly L Desmond, et al.
Pageof 13